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Estimating Penetrance Parameters, by Zo¨llner and
Pritchard (p. 605)
When an association between a genetic variant and a phe-
notype is identified, the next step is often to determine
the size of the effect of that variant on the phenotype.
There are pitfalls involved if this is done using data from
the same population in which the association was found,
because of the ascertainment effect associated with the
selection of that data set. Odds ratios calculated in this
fashion are often discovered to be higher than the real
effect, and this creates problems in subsequent attempts
at replication, because of inflated power expectations. One
method for proper determination of the variants’ effect is
analysis of the association in a completely independent
and random group of individuals. However, this can be
cost and time prohibitive, so it was a goal of Zo¨llner and
Pritchard to be able to correct for the bias in the original
data set. Their proposed method used data about the prev-
alence of the phenotype in the general population to es-
tablish an estimator for the penetrance of the variant. Sim-
ulations demonstrated that power calculations with use
of odds ratios estimated with their algorithm were more
accurate. Additionally, using real data from the original
study that demonstrated an association between PPARg
and diabetes, the authors were able to properly correct for
the ascertainment bias and to determine the effect of the
variant more accurately.
Regularized Regression Haplotype Analysis, by Li
et al. (p. 705)
Using haplotype methods in association studies has its
advantages, but arguments remain over the best way to
choose the haplotypes for analysis. Techniques employing
linkage-disequilibrium blocks as guidelines can be limit-
ing, whereas sliding-window strategies can lose a lot of
power because of the large number of tests performed.
Sliding-window methods with a fixed window length can
be problematic when large regions are analyzed, so algo-
rithms using variable-sized windows have been developed.
To avoid losing a great deal of power to corrections, efforts
have been made to limit the size and number of the win-
dows, but current methods may lead to a loss of sensitivity
or can be very time consuming. Li et al. propose a strategy
that first predicts maximum window size on the basis of
haplotype diversity and sample size and then performs
an efficient joint analysis with use of a regularized re-
gression. The regression is able to take into account re-
dundancy and complementariness of the haplotypes, to
decrease the effective number of degrees of freedom, and,
subsequently, to improve power.
Admixture Mapping of Inflammatory Markers, by
Reich et al. (p. 716)
Circulating levels of inflammatory markers are associated
with risk of developing various diseases, including athero-
sclerosis, myocardial infarction, stroke, and autoimmune
disease. Differences in the levels of certain markers have
been observed between European Americans and African
Americans, so Reich et al. predicted that they might be
able to identify genetic loci associated with marker levels
through the use of admixture-mapping techniques. In a
group of African Americans, they found that the levels
of interleukin 6 soluble receptor, IL6 SR, increased with
higher amounts of European ancestry, whereas high C re-
active protein levels were correlated with the amounts of
African ancestry. An admixture scan for association with
IL6 SR levels identified a locus on chromosome 1 that con-
tained the gene (IL6R) that encodes the interleukin 6 re-
ceptor. This gene was of particular interest because its pro-
tein, IL6R, localizes to cell surfaces and gets processed to
release its soluble form, IL6 SR. Fine mapping with SNPs
in the region revealed that IL6 SR levels are associated with
an IL6R SNP that was expected to interfere with the cleav-
ing of IL6R to IL6 SR.
Etruscan Origins: Novel Clues from mtDNA, by
Achilli et al. (p. 759)
The Etruscans, an ancient population with a unique cul-
ture and language, lived in central Italy in the 9th century
B.C. They were a highly sophisticated people and differed
significantly from other groups that lived in the region.
Although it is understood that their demise came about
when the region was conquered by the Romans, their or-
igin is a matter of controversy. Some believe that the Etrus-
cans were native Italians who developed into their own
group, whereas others support the idea that they were de-
scendants of immigrants who came from the Near East.
To gain more insight into this mystery, Achilli et al. chose
to study the mtDNA of people living in modern-day Tus-
cany. This region lies within that settled by the Etruscans
and has remained somewhat isolated, so it was hoped that
traces of the ancient people might still remain. The au-
thors found that many of the sequences analyzed existed
only in the Near East and were not found in surrounding
Italy or Europe. These data support the hypothesis that
the founders of the Etruscan people were originally from
the Near East.
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INI1 in Familial Schwannomatosis, by Hulsebos et
al. (p. 805)
Patients with schwannomatosis develop rare neoplasms
called “schwannomas” that are benign and encapsulated.
These tumors are also found in people with neurofi-
bromatosis type 2, which is caused by mutations in NF2.
Somatic mutations in NF2 have also been identified in
the schwannomas associated with schwannomatosis, but
linkage studies of schwannomatosis-affected families have
suggested that an independent region on chromosome
22 is the causative locus. One gene at this locus, INI1, is
a tumor-suppressor gene that has been shown elsewhere
to be mutated in families in which infants develop ma-
lignant rhabdoid tumors. Here, Hulsebos et al. decided to
examine whether INI1 mutations also contribute to fa-
milial schwannomatosis, by sequencing the gene in a pro-
band and her father. Both were found to be heterozygous
for a germline nonsense mutation in exon 1. Immunohis-
tochemistry of sections of tumors from the patients re-
vealed that some cells were positive for INI1 whereas oth-
ers were negative, suggesting that loss of heterozygosity
in the negative cells contributed to the development of
the neoplasm. This mosaic pattern was in contrast to the
even staining observed in schwannomas from patients
without schwannomatosis.
This Month on the Cover
Mendelian Inheritance in Man (MIM), the ultimate re-
source describing human genes and genetic disorders, was
first published in 1966 by Dr. Victor McKusick (Mendelian
Inheritance in Man: Catalogs of Autosomal Dominant, Autoso-
mal Recessive and X-Linked Phenotypes. Johns Hopkins Uni-
versity Press, Baltimore). Several print editions followed,
until it was eventually published and maintained online.
See Dr. McKusick’s historical account of the development
of MIM and the online version, OMIM, in this month’s
Perspectives feature “Perspective on MIM/OMIM,” starting
on page 588. An introduction is provided below by Dr.
Arno Motulsky. On the cover, the growth of knowledge
compiled through time can be seen by the number of
known loci indicated on the X chromosome at three time
points: 1975, 1983, and 1998.
Robin E. Williamson
Deputy Editor
This Month in Perspectives
This month’s contribution to the “Perspectives” series by
Victor McKusick is a “must read” article for human and
medical geneticists. Most readers of the AJHG are well ac-
quainted with McKusick’s comprehensive catalogue of hu-
man genes, mutations, phenotypes, and modes of inher-
itance (Mendelian Inheritance in Man, or MIM). The cat-
alogue has been fully available online (OMIM) for some
time and is updated periodically. In January 2007, we
reached a score of 117,000 entries and almost 15,000 mu-
tations catalogued on OMIM! Victor furnishes a perspec-
tive on the origin and history of this monumental Web
resource and provides detailed explanations for the ratio-
nale of classifying genes, mutations, and phenotypes, with
an emphasis on gene-phenotype relationships. He points
out that non-Mendelian genetics—such as chromosomal
and epigenetic variation, as well as multifactorial or com-
plex disorders and related susceptibility alleles—are be-
ginning to be included in OMIM. The “Perspectives” ar-
ticle provides a wide-ranging exposition about use of the
catalogue for insights into medical and human genetics
that, in earlier times, were discussed in the front matter
of the periodically published MIM volumes and were read
with anticipation by many of us. A book with both old
and new content of this sort will be of much interest in
the future. Since OMIM continues to be a valuable re-
source for geneticists and clinically for genetics counselors
and helps in teaching and research of genetic diseases, a
variety of users (including geneticists who study nonhu-
man species) will profit practically and conceptually from
a careful reading of this “Perspectives” article.
Arno Motulsky
